Displaying items by tag: adults

University of Alabama at Birmingham is seeking cigarette smokers who would like to quit smoking for participation in a scientific research study. The research study involves free counseling and treatment provided in a comfortable, supportive setting. The study may involve ingestion of psilocybin, a psychoactive substance found in psychedelic mushrooms that have been used as a sacrament in various cultures. Some research studies have suggested that psychedelics, when administered under interpersonally supportive and well-prepared conditions, may be effective in helping people overcome addictions.

Questionnaires, interviews, and biological measures of smoking will be used to assess the treatment's effects on mood and smoking. Participants will be compensated $50 per session. If you would like to discuss the possibility of volunteering, please call 205-996-1198, or go to www.quitsmokingbaltimore.org for more information about the study and to complete the online study prescreener for the UAB site. Confidentiality will be maintained for all applicants and participants.

Volunteers must be 21 years of age or older, and must live within travel distance of the study site in Birmingham.
Published in Clinical Trials
There is an ongoing psychedelic clinical research study evaluating the safety and efficacy of an intranasal study drug for patients with treatment resistant depression.

To qualify patients need to be 18-75 years of age, failed to respond to an adequate dose & duration of at least 2 medicines for depression. If currently taking antidepressants, willing and able to discontinue.

If eligible, study participants will be expected to abstain from illicit drugs for the duration of the trial & attend all study visits & follow instructions from the study doctor. Study examinations will be at no cost to you.

For more information please contact 205-996-1198 or spremani@uab.edu
Published in Clinical Trials
Treatment for Urge Urinary Leakage: BEST Study

This study will compare the effectiveness of two different treatments for urge urinary incontinence (UUI). One treatment is Botox injections in the bladder, and the other is an oral medication (mirabegron or vibegron).

Participants compensated up to $425.

For more information about this study, please email or at urogynecology@uabmc.edu or 205-934-5498.
Published in Clinical Trials
Are you experiencing pain due to endometriosis? Please consider joining a research study looking at a potential new medication to help women experiencing moderate to severe endometriosis-related pain. Study medication provided at no cost. Participants receive compensation for each visit completed. For more information please call 205-934-1322 or email slangan@uabmc.edu.
Published in Clinical Trials
Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at, genesis@uabmc.edu or call us at (205) 975-3956 if you are interested.
Published in Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in Clinical Trials
DAY or NIGHT, when is the best time to take your blood pressure medication?

Help us find out by participating in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.
Published in Clinical Trials
Healthy participants needed if you are:
  • 18-75 years old
  • No diagnosis of any neurological disorders or psychiatric problems
  • No history of problematic drug/alcohol use in the last 3 months
For more information and to determine eligibility, please call the Neuroscience Laboratory of Social Behavior at (205) 934-8203 or email nlsb.uab@gmail.com.
**Compensation is provided**
Published in Clinical Trials
UAB is looking for participants for a study investigating the effects of a new study medication on symptoms of fibromyalgia. We are looking for women aged 25-65 who are diagnosed with fibromyalgia OR are experiencing chronic widespread bodily pain. Participants will come to UAB for 7 study visits over a 3-month period. Participants will be compensated for completing all study visits.

Please call 205-996-1198 if interested.
Published in Clinical Trials
The purpose of this study is to evaluate if COPD is caused by exposure to heavy metals. This study will include a medical history review, a brief physical examination, spirometry, exhaled breath condensate, urine sample, blood collection, and a bronchoscopy/bronchoalveolar lavage procedure. Those who qualify will receive compensation for their time. Participation is voluntary. Participants in the study must: be 18 to 65 years of age; live in defined zip codes, 35207, 35217, 35214; and fulfill other eligibility criteria to include a medical and medication history for evaluation. For more information, please call (205) 996-1769 or email uabsuperfund@uabmc.edu.
Published in Clinical Trials
The purpose of this research study is to analyze cells and fluid obtained from the lungs and determine mechanism(s) by which these cells are impaired in their ability to reduce the severity of lung infections. This study will include a medical history review, a brief physical examination, spirometry, and a bronchoscopy/bronchoalveolar lavage procedure. Those who qualify will receive compensation for their time. Participation is voluntary. Participants in the study must: be 18 to 65 years of age; live in defined zip codes, 35207, 35217, 35214; and fulfill other eligibility criteria to include a medical and medication history for evaluation. For more information, please call (205) 996-1769 or email uabsuperfund@uabmc.edu.
Published in Clinical Trials
We are asking you to take part in this research study because you are a resident of North Birmingham or Tarrant and may have exposure to arsenic due to industrial activity in the area. This research study is now enrolling adults within the zip codes, 35207 and 35217. After confirming enrollment eligibility, those who qualify will be randomized to receive either folic acid supplementation or a placebo at no cost. We will collect a brief medical and medication history, collect samples of urine and blood, perform spirometry testing, and complete a respiratory questionnaire.

Participation is voluntary, and you will be compensated for your time. Participants in the study must: be 18 to 65 years of age; a resident of 35207 or 35217 zip codes; not currently pregnant or currently taking folic acid; and fulfill other eligibility criteria. For more information, please call (205) 996-1769 or email uabsuperfund@uabmc.edu.
Published in Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in Clinical Trials
UAB researchers are looking for adults (ages 25-65) who are suffering from demoralization - feelings of hopelessness or meaninglessness - to participate in a research study evaluating a novel medication.

To see if you qualify call 205-379-7527.
Published in Clinical Trials
Congenital CMV infection is the most common infection passed from the mother to baby during pregnancy. It is also the most common non-hereditary cause of hearing loss and brain damage in children. You or your child will have 3 injections, several months apart. You will have approximately 11 clinic visits over the 18 month study period. Saliva swabs, urine, and blood samples will be required. Compensation for participation is available. To learn more, visit CMVibeTrial.com or contact the UAB study team: 205-638-2629 or mlpurser@uabmc.edu
Published in Clinical Trials

Help us find out by joining our study at UAB by participating in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.

Published in Clinical Trials
Are you tired of constantly fearing urinary leakage? Say goodbye to embarrassing accidents and take control of your life! We believe in living life to the fullest without worrying about Urgency Urinary Leakage. Compensation is provided.

Call us today at (205) 934-5498 to join our urogynecology clinical trial and find the perfect treatment plan tailored to you.
Published in Clinical Trials
You may be eligible to participate if you identify as female, White or African American, are aged 35-65, and have a BMI of 30+. Participants will receive $50 as thanks for their participation.

This study is a 5-hour workshop delivered in groups that is based on principles of acceptance and commitment therapy (ACT). Participants will learn new skills to facilitate the adoption of healthy lifestyle behaviors, such as eating a healthy diet and exercising regularly. These skills include identifying values, tolerating the discomfort associated with lifestyle change, identifying self-sabotaging thoughts, and more!

For more information, please contact Andrea at andrealdavis@uabmc.edu or 205-206-9434.
Published in Clinical Trials
Do you identify as an individual living with cancer and part of the LGBTQIA+ community or a care partner of someone in this community? A research lab at the University of Alabama at Birmingham is looking to learn about the day-to-day experiences of LGBTQIA+ cancer survivors and their care partners. We are interested in how individuals manage difficult situations related to their respective roles in their relationships. Individuals living with cancer often encounter stressful situations that can impact their mood and any additional stressors from living as a sexual or gender minority with a lack of resources adds an increased risk of experiencing stressful situations. The goal of this work is to develop resources that better support the well-being of LGBTQIA+ individuals living with cancer and their care partners. This study will take place FULLY online with completion of daily surveys. All participants will be compensated. To learn more about our study contact us at starlab@uab.edu
Published in Clinical Trials
The University of Alabama at Birmingham (UAB) is inviting Hispanic or Latino/a family caregivers to complete short surveys for our study. Your answers will help us understand your daily experiences and develop services to better support caregivers in the community. You will be paid for your time. Your answers will remain anonymous. To learn more contact us at starlab@uab.edu or call Lorelí Alvarez at 205-996-0339.
To be contacted by the research team register here: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU

¿Cuidas de un familiar con problemas de memoria o demencia/enfermedad de Alzheimer?
La Universidad de Alabama en Birmingham (UAB) está invitando a cuidadores familiares hispanos y latinos para que completen breves encuestas para nuestro proyecto. Tus respuestas ayudarán a comprender mejor las experiencias del día a día y a desarrollar servicios para apoyar mejor a los cuidadores familiares de la comunidad. Les compensaremos por su participación. Sus respuestas permanecerán anónimas. Para saber más escribe a starlab@uab.edu o llama por teléfono al 205-996-0339 y pregunta por Lorelí Alvarez.
Para ser contactado por el equipo de investigación haga click aquí: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU
Published in Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in Clinical Trials
Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested
Published in Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in Clinical Trials
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
The UAB TRIP Lab is studying the effects of concussion on driving among adolescents and young adults, from acute post-injury to symptom resolution. We are in search of 16-24 year olds who have had a concussion within the last 10 days AND who have NOT had a concussion (control group) to participate in a longitudinal study. Participants will visit UAB once per week, where they will drive in a fully immersive, state-of-the-art driving simulator and complete some cognitive and/or balance tasks. Participant will also complete surveys throughout the week. Participants are compensated up to $610 for their time. If interested, please contact the UAB TRIP Lab, (205) 975-9440 | TRIPLAB@UAB.EDU
Published in Clinical Trials
Page 2 of 4